-
Loading metrics
A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus
-
Jennifer A. Jenks,
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America
⨯ - Sharmi Amin,
- Madeline R. Sponholtz,
- Amit Kumar,
- Daniel Wrapp,
- Sravani Venkatayogi,
- Joshua J. Tu,
- Krithika Karthigeyan,
- Sarah M. Valencia,
- Megan Connors,
- Melissa J. Harnois,
- Bhavna Hora,
- Eric Rochat,
- Jason S. McLellan,
- Kevin Wiehe ,
- [ ... ],
-
Sallie R. Permar
Contributed equally to this work with: Kevin Wiehe, Sallie R. Permar
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: sallie.permar@med.cornell.edu
Affiliations Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America, Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America
⨯ - [ view all ]
- [ view less ]
https://orcid.org/0000-0002-6865-5615
A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus
- Jennifer A. Jenks,
- Sharmi Amin,
- Madeline R. Sponholtz,
- Amit Kumar,
- Daniel Wrapp,
- Sravani Venkatayogi,
- Joshua J. Tu,
- Krithika Karthigeyan,
- Sarah M. Valencia,
- Megan Connors
-
- Published: January 20, 2023
- https://doi.org/10.1371/journal.ppat.1011107